Established in 1999, this South Korean company has over two decades of experience in Rx innovative drug manufacturing and distribution for niche therapeutic markets. Portfolio covers urology, gastrointestinal, oncology, and immunology therapy areas in solid and injectable forms. Serves domestic and select Asian markets with a focus on addressing unmet medical needs.